Replies to post #1150281 on MOMO'S BREAKOUT BOARD

[Abondanceinvest]

gm MOMO, SREH !!radar>>Interesting$

[Abondanceinvest]

>>>>>>>>FNMA <<ATM machine again!!Solid..stock

[carl405040]

I have never posted before. My question is if you knew of a gold miner with 5,000,000 proven ounces of gold to mine, all in CANADA, and selling for .06===how do you explain this???? Other gold miners with even less gold proven are selling for 2 to 3 dollars a share. CGJCF (Carlisle Gold) ANY OPINIONS?

[balamidas]

good morning MOMO~

[The Whale]

Oh my. SKTO http://www.medicalgreens.com/

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[balamidas]

STOA(0.0045) MUST READ MONSTER MERGER DD by all >>>


the deal :


on 25 Feb,2013

Iris’s new waste-to-energy plant in Phuket a revenue churner


The investment is through its newly incorporated company in Hong Kong, Regal Energy Limited, which owns 65% of equity shares of the newly-formed joint-venture company, Weinan IRIS Envirowerkz Zhouji Renewable Resources Co Ltd.


plant expected to generated gross annual revenue of between RM55 million (US$17.71 million) and RM60 million based on current load. -

http://www.greenprospectsasia.com/content/iris%E2%80%99s-new-waste-energy-plant-phuket-revenue-churner#sthash.ktdup5Wp.dpuf






and on 18 March ,2013


Sitoa Global Signs Letter of Intent with IRIS Corporation Berhad


"IRIS and Sitoa, both of which are technology companies, identified the Waste-To-Energy and Renewable Energy businesses as a growing and timely priority and thus appropriate to be acquired by Sitoa because they could potentially achieve an attractive valuation on a U.S. Stock exchange, enhance shareholder value, attract growth capital and expand its business."


merger expected to close before June 30

The following is from STOA news:

owner of certain selected waste-to-energy assets; and other Renewable Energy and waste to energy "Pipeline Project" assets, owned by third-party owners and with whom IRIS will secure appropriate agreements to these projects, technologies, rights and obligations (the "IRIS Renewable Energy Business") in respect of a proposed transaction in which Sitoa will purchase IRIS Renewable Energy Asset plus waste-to-energy assets owned by other third parties in exchange for common shares in Sitoa. On completion of the acquisitions, IRIS will become the majority shareholder of Sitoa as a result of the share exchange and Sitoa will pursue the development of the acquired renewable energy business in accordance with IRIS's business plan. The terms of the acquisition will be more particularly set forth in the Definitive Agreements to be mutually agreed upon by the Parties and the acquisition expects to be completed by the end of the Second Quarter, 2013.


and before June 30 MERGER coming ...


STOA website showing:"FUTURE HOME OF SOMETHING COOL"


it is coming ...

http://www.sitoaglobal.com/




STOA transfer agent confirmed 264 million shares yesterday



http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88970924



watch for a big run here(multiple pennies)

[nocpimping]

SREH is now a hidden gem under new ownership. I'm adding there everyday I get spare bullets.

[balamidas]

EVRM 0.0014 ONE LEFT ~

[balamidas]

STOA(0.006)~MIND BLOWING REVERSE MERGER before June 30 >>>

we don't see that often in Pennyland ...


the deal :


on 25 Feb,2013

Iris’s new waste-to-energy plant in Phuket a revenue churner


The investment is through its newly incorporated company in Hong Kong, Regal Energy Limited, which owns 65% of equity shares of the newly-formed joint-venture company, Weinan IRIS Envirowerkz Zhouji Renewable Resources Co Ltd.


plant expected to generated gross annual revenue of between RM55 million (US$17.71 million) and RM60 million based on current load. -

http://www.greenprospectsasia.com/content/iris%E2%80%99s-new-waste-energy-plant-phuket-revenue-churner#sthash.ktdup5Wp.dpuf



the letter of intent with STOA


and on 18 March ,2013


Sitoa Global Signs Letter of Intent with IRIS Corporation Berhad


"IRIS and Sitoa, both of which are technology companies, identified the Waste-To-Energy and Renewable Energy businesses as a growing and timely priority and thus appropriate to be acquired by Sitoa because they could potentially achieve an attractive valuation on a U.S. Stock exchange, enhance shareholder value, attract growth capital and expand its business."


merger expected to close before June 30

The following is from STOA news:

owner of certain selected waste-to-energy assets; and other Renewable Energy and waste to energy "Pipeline Project" assets, owned by third-party owners and with whom IRIS will secure appropriate agreements to these projects, technologies, rights and obligations (the "IRIS Renewable Energy Business") in respect of a proposed transaction in which Sitoa will purchase IRIS Renewable Energy Asset plus waste-to-energy assets owned by other third parties in exchange for common shares in Sitoa. On completion of the acquisitions, IRIS will become the majority shareholder of Sitoa as a result of the share exchange and Sitoa will pursue the development of the acquired renewable energy business in accordance with IRIS's business plan. The terms of the acquisition will be more particularly set forth in the Definitive Agreements to be mutually agreed upon by the Parties and the acquisition expects to be completed by the end of the Second Quarter, 2013.


and before June 30 MERGER coming ...


STOA website showing:"FUTURE HOME OF SOMETHING COOL"


it is coming ...

http://www.sitoaglobal.com/



CONFIRMATION from IRIS corp page on Businessweek >>


they have the merger listed under their MERGER/ACQUISITION page


Transactions by IRIS CORP BHD (ICB) in the last 6 months




http://investing.businessweek.com/research/stocks/transactions/transactions.asp?ticker=ICB:MK



Announced 03/18/13

Iris Corporation Bhd., Renewable Energy and Waste-to-energy Assets
Merger/Acquisition

Sitoa Global Inc. (OTCPK:STOA) entered into a letter of intent to acquire renewable energy and waste-to-energy assets from Iris Corporation Bhd. (KLSE:IRIS) and other third parties on March 18, 2013. Sitoa Global Inc. entered into a letter of intent with IRIS Corporation Berhad, the owner of certain selected waste-to-energy assets; and other renewable energy and waste to energy pipeline project assets, owned by third-party owners and with whom, IRIS will secure appropriate agreements to these projects, technologies, rights and obligations in respect of a proposed transaction, in which Sitoa will purchase IRIS renewable energy asset plus waste-to-energy assets owned by other third parties, in exchange for common shares in Sitoa. On completion of the acquisitions, IRIS will become the majority shareholder of Sitoa as a result of the share exchange and Sitoa will pursue the development of the acquired renewable energy business in accordance with IRIS's business plan. The acquisition expects to be completed by the end of the second quarter, 2013.







STOA transfer agent confirmed 264 million shares this week



http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88970924



watch for a big run here(multiple pennies)


the STOA/IRIS corp merger is about very very very big dollars >>>


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=89037150



with the STOA merger valuation,

IRIS corp is building with STOA a huge waste -to-energy company

and we know that plant that will supply the New company after the merger is expected to generated gross annual revenue of between RM55 million (US$17.71 million) and RM60 million based on current load. - See more at: http://www.greenprospectsasia.com/content/iris%E2%80%99s-new-waste-energy-plant-phuket-revenue-churner#sthash.UyMoG4yz.dpuf

a company generating around 18 million $ in revenues worth at least 4 times that in market cap around 80 million $




and

we have confirmed this week an O/S of 264 million with the TA


so if we inject that value in STOA onm the actual SS logically

80 million$ /264 million shares =0.30 price per share

but i am not taking in account yet the shares to be added for the acquisition


However, if they create/issue Preferred Shares to exist as the controlling interest with non-dilutive measures taken by having the Preferred Shares to be converted on a “1 for 1 basis into common” (which would never be converted to keep from losing the controlling interest) with a 1 for ??? (whatever ratio determined) basis amount for votes to cover 51% or greater of the votes, then the OS can remain the same at 264 million shares which would enhance its valuation since the lower the OS is… the greater the valuation of the stock/company will be.


from STOA PR:

"IRIS will become the majority shareholder of Sitoa as a result of the share exchange"


those 0.25/0.30 are inplay with STOA

[balamidas]

good morning MOMO~

[mvp_money]

$BMCS 005s super thin pennies coming here

[balamidas]

good morning MOMO~

[balamidas]

SREH 0.0025 big news out

[balamidas]

CARN 0.0095 >>0.012 the 200 ma boom coming ~

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[johnkenny]

MOMO- Are you talking about ice skates?

[balamidas]

CLNP 0.0029 one left ~

[balamidas]

CLNP 0.0029 big buys on BIG HEMP NEWS ~

[balamidas]

CLNP 0.0029 falling >>0.005 on the way ~

[Komando Robot]

NOHO .001s falling +25% Green ~

Only 200M OS

[Abondanceinvest]

Gm MOMO,ARGEF-RGX.V BREAKING NEWS - ARGEX (RGX-V) ANNOUNCES PURCHASE AGREEMENT WITH PPG?


ARGEX ANNOUNCES PURCHASE AGREEMENT WITH PPG

Argex Titanium Inc. has entered into a long-term supply agreement with PPG Industries Inc. relating to titanium dioxide pigment suitable for various end-use applications by PPG.

PPG is the world's leading coatings and specialty products company, serving customers in construction, consumer products, industrial and transportation markets and aftermarkets. PPG operates in nearly 70 countries around the world, with sales in 2012 of $15.2-billion (U.S.).

The supply agreement and a concurrently executed research services agreement between PPG and Argex, whereby PPG will provide continued research and development support to both optimize Argex pigment-grade TiO2 for paints and coatings, and combine PPG's coatings technology and expertise with Argex's TiO2 proprietary processing technology, replace the collaboration agreement signed by the two parties that was announced in April, 2012.

Roy Bonnell, Argex president and chief executive officer, said: "The agreements with PPG are a significant milestone for our company. Our relationship with PPG has greatly assisted with our stated goal to move towards production. We are very pleased that PPG will be our first customer for TiO2 pigment suitable for use in its architectural paint production. We are also pleased that we will continue our collaboration with PPG to optimize our product for other various end-use applications."

"These agreements and our ongoing collaboration with Argex are demonstrative of PPG's stated intent to leverage our expertise to secure an enhanced supply of critical raw materials," said Charles Kahle, PPG chief technology officer, and vice-president, research and development, coatings.

PPG previously manufactured titanium dioxide using the chloride process at its former Natrium, W.Va., chemicals plant and sold titanium dioxide pigment for coatings and other end-use applications. Titanium dioxide is a raw material widely used in the paint and coatings industry as pigment for its hiding, durability and whiteness characteristics.



Argex announces purchase agreement with PPG


2013-06-27 16:32 ET - News Release


Argex announces purchase agreement with PPG

Canada NewsWire

MONTREAL, June 27, 2013

MONTREAL, June 27, 2013 /CNW Telbec/ - Argex Titanium Inc. (TSXV: RGX) announced today that it has entered into a long-term supply agreement with PPG Industries Inc. (NYSE: PPG) relating to titanium dioxide (TiO2) pigment suitable for various end-use applications by PPG.

PPG is the world's leading coatings and specialty products company, serving customers in construction, consumer products, industrial and transportation markets and aftermarkets. PPG operates in nearly 70 countries around the world, with sales in 2012 of US$15.2 billion.

The supply agreement and a concurrently executed research services agreement between PPG and Argex, whereby PPG will provide continued research and development support to both optimize Argex pigment grade TiO2 for paints and coatings and combine PPG's coatings technology and expertise with Argex's TiO2 proprietary processing technology, replace the collaboration agreement signed by the two parties that was announced in April, 2012.

Roy Bonnell, Argex President and Chief Executive Officer, said, "The agreements with PPG are a significant milestone for our Company. Our relationship with PPG has greatly assisted with our stated goal to move towards production. We are very pleased that PPG will be our first customer for TiO2 pigment suitable for use in its architectural paint production. We are also pleased that we will continue our collaboration with PPG to optimize our product for other various end-use applications."

"These agreements and our ongoing collaboration with Argex are demonstrative of PPG's stated intent to leverage our expertise to secure an enhanced supply of critical raw materials," said Charles F. Kahle II, PPG Chief Technology Officer and Vice President, Research and Development, Coatings.

PPG previously manufactured titanium dioxide using the chloride process at its former Natrium, W.Va., chemicals plant and sold titanium dioxide pigment for coatings and other end-use applications. Titanium dioxide is a raw material widely used in the paint and coatings industry as pigment for its hiding, durability and whiteness characteristics.

About Argex Titanium Inc.

ARGEX Titanium Inc. is a near-term producer of Titanium Dioxide (TiO2). With a primary goal of advancing rapidly towards production, Argex has adopted a simple and low-risk strategy for the scale-up of its proprietary process that allows it to produce high quality TiO2 pigment directly from run-of-mine material from a variety of sources. The closed-loop process is environmentally friendly and produces minimal inert tailings.

The feasibility study for the process is nearing completion.

The Argex R&D Centre and its first industrial sized production module will be situated in Salaberry-de-Valleyfield, Quebec. The company expects its industrial plant to be operational in early 2015. The location of the site can be viewed at Argex Valleyfield.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Argex Titanium Inc.

Contact:

<p> Roy Bonnell, President and Chief Executive Officer<br/> Argex Titanium Inc.<br/> 514 788-8923<br/> <a href="mailto:[e-mail]">[e-mail]</a> </p> <p> Argex Titanium Inc.<br/> TSX-V: RGX </p> <p> INVESTOR RELATIONS:<br/> Dave Burwell<br/> The Howard Group<br/> 1-888-221-0915<br/> <a href="mailto:[e-mail]">[e-mail]</a> </p> <p> MEDIA:<br/> Sarah Moreau, Consultant, Financial & Regulatory Affairs<br/> H+K Strategies<br/> 514 395-0375, ext.234<br/> <a href="mailto:[e-mail]">[e-mail]</a> </p>

[Abondanceinvest]

BRAV 2 pr$ out!! this morning

Ab$

[balamidas]

SREH 0.0019 one left

[balamidas]

NXHZ 0.03 one left ~

[Abondanceinvest]

SREH agree with you MOMO nice potential$
Ab$ have a nice week-end

[Abondanceinvest]

ARGEF-RGX.V BREAKING NEWS - ARGEX (RGX-V) ANNOUNCES PURCHASE AGREEMENT WITH PPG?


ARGEX ANNOUNCES PURCHASE AGREEMENT WITH PPG

Argex Titanium Inc. has entered into a long-term supply agreement with PPG Industries Inc. relating to titanium dioxide pigment suitable for various end-use applications by PPG.

PPG is the world's leading coatings and specialty products company, serving customers in construction, consumer products, industrial and transportation markets and aftermarkets. PPG operates in nearly 70 countries around the world, with sales in 2012 of $15.2-billion (U.S.).

The supply agreement and a concurrently executed research services agreement between PPG and Argex, whereby PPG will provide continued research and development support to both optimize Argex pigment-grade TiO2 for paints and coatings, and combine PPG's coatings technology and expertise with Argex's TiO2 proprietary processing technology, replace the collaboration agreement signed by the two parties that was announced in April, 2012.

Roy Bonnell, Argex president and chief executive officer, said: "The agreements with PPG are a significant milestone for our company. Our relationship with PPG has greatly assisted with our stated goal to move towards production. We are very pleased that PPG will be our first customer for TiO2 pigment suitable for use in its architectural paint production. We are also pleased that we will continue our collaboration with PPG to optimize our product for other various end-use applications."

"These agreements and our ongoing collaboration with Argex are demonstrative of PPG's stated intent to leverage our expertise to secure an enhanced supply of critical raw materials," said Charles Kahle, PPG chief technology officer, and vice-president, research and development, coatings.

PPG previously manufactured titanium dioxide using the chloride process at its former Natrium, W.Va., chemicals plant and sold titanium dioxide pigment for coatings and other end-use applications. Titanium dioxide is a raw material widely used in the paint and coatings industry as pigment for its hiding, durability and whiteness characteristics.



Argex announces purchase agreement with PPG


2013-06-27 16:32 ET - News Release


Argex announces purchase agreement with PPG

Canada NewsWire

MONTREAL, June 27, 2013

MONTREAL, June 27, 2013 /CNW Telbec/ - Argex Titanium Inc. (TSXV: RGX) announced today that it has entered into a long-term supply agreement with PPG Industries Inc. (NYSE: PPG) relating to titanium dioxide (TiO2) pigment suitable for various end-use applications by PPG.

PPG is the world's leading coatings and specialty products company, serving customers in construction, consumer products, industrial and transportation markets and aftermarkets. PPG operates in nearly 70 countries around the world, with sales in 2012 of US$15.2 billion.

The supply agreement and a concurrently executed research services agreement between PPG and Argex, whereby PPG will provide continued research and development support to both optimize Argex pigment grade TiO2 for paints and coatings and combine PPG's coatings technology and expertise with Argex's TiO2 proprietary processing technology, replace the collaboration agreement signed by the two parties that was announced in April, 2012.

Roy Bonnell, Argex President and Chief Executive Officer, said, "The agreements with PPG are a significant milestone for our Company. Our relationship with PPG has greatly assisted with our stated goal to move towards production. We are very pleased that PPG will be our first customer for TiO2 pigment suitable for use in its architectural paint production. We are also pleased that we will continue our collaboration with PPG to optimize our product for other various end-use applications."

"These agreements and our ongoing collaboration with Argex are demonstrative of PPG's stated intent to leverage our expertise to secure an enhanced supply of critical raw materials," said Charles F. Kahle II, PPG Chief Technology Officer and Vice President, Research and Development, Coatings.

PPG previously manufactured titanium dioxide using the chloride process at its former Natrium, W.Va., chemicals plant and sold titanium dioxide pigment for coatings and other end-use applications. Titanium dioxide is a raw material widely used in the paint and coatings industry as pigment for its hiding, durability and whiteness characteristics.

About Argex Titanium Inc.

ARGEX Titanium Inc. is a near-term producer of Titanium Dioxide (TiO2). With a primary goal of advancing rapidly towards production, Argex has adopted a simple and low-risk strategy for the scale-up of its proprietary process that allows it to produce high quality TiO2 pigment directly from run-of-mine material from a variety of sources. The closed-loop process is environmentally friendly and produces minimal inert tailings.

The feasibility study for the process is nearing completion.

The Argex R&D Centre and its first industrial sized production module will be situated in Salaberry-de-Valleyfield, Quebec. The company expects its industrial plant to be operational in early 2015. The location of the site can be viewed at Argex Valleyfield.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Argex Titanium Inc.

Contact:

<p> Roy Bonnell, President and Chief Executive Officer<br/> Argex Titanium Inc.<br/> 514 788-8923<br/> <a href="mailto:[e-mail]">[e-mail]</a> </p> <p> Argex Titanium Inc.<br/> TSX-V: RGX </p> <p> INVESTOR RELATIONS:<br/> Dave Burwell<br/> The Howard Group<br/> 1-888-221-0915<br/> <a href="mailto:[e-mail]">[e-mail]</a> </p> <p> MEDIA:<br/> Sarah Moreau, Consultant, Financial & Regulatory Affairs<br/> H+K Strategies<br/> 514 395-0375, ext.234<br/> <a href="mailto:[e-mail]">[e-mail]</a> </p>

[balamidas]

good morning MOMO~

[Abondanceinvest]

Gm MOMO SREH Breakout$ in preparation
Ab$

[Abondanceinvest]

>>>>>>>>>HAPPY 4th <<<<<<<<<<and_take_care!!

Ab$

[Abondanceinvest]

MOMO'>>>>>>>BISU<<<<<<<$$_ALERT!!$$_

[energie]

$BISU New$$ >>Type2Defense(TM) Available on the>>Amazon<< Healthy Provisions Online Store
Date : 07/08/2013 @ 6:30AM
Source : Marketwired
Stock : Bio-solutions Corp. (QB) (BISU)
Quote : 0.0175 0.0 (0.00%) @ 4:32AM


Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store
Print
Alert
Bio-solutions Corp. (QB) (USOTC:BISU)
Intraday Stock Chart
Today : Monday 8 July 2013



Bio-Solutions Corp. (OTCQB:BISU)(PINKSHEETS:BISU) (www.BioSolutionsCorp.com) has done it! In this first step to the company's expansion process across the USA and commitment to growth across America, management celebrates the national roll-out of its flagship product Type2Defense(TM) on the Healthy Provisions Amazon store via its partnership agreement with Kee Holdings Inc. The product can be purchased by following the online ordering link on the company website at: www.biosolutionscorp.com.

Kee Holdings Inc. is a leading procurer of health, nutrition and wellness products leading the way to many of the internet giants online today. Since 2006, Kee Holdings has grown to represent over 7,500 well-known consumer products and offers both wholesale and drop ship fulfillment strategies to clients such as Amazon.com and Overstock.com. Kee Holdings will be managing all product orders and shipping for Bio-Solution Corp's on-line sales.

Type2Defense(TM) is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

"We are very excited to be bringing Type2Defense(TM) to the consumer on the Healthy Provisions Amazon store and we highly appreciate the support that Amazon and its partners offer to manufacturers and suppliers. We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2Defense(TM) is aimed at filling in that gap and our company is confident that it will benefit from the $15 billion dollar U.S diabetes market," said Bill Gallagher, president and CEO at Bio-Solutions Corporation.

Consumers can find more information about the product by going to http://www.biosolutionscorp.com/products/.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

Contacts:

Bio-Solutions Corp.

William Gallagher

Chief Executive Officer

210-373-8104

[e-mail]



Bio-Solutions Corp.

Josh Williams

Endorsement Deal Coordinator

312-636-1471

[e-mail]

www.biosolutionscorp.com

[energie]

$BISU Kee Holdings has grown to represent over 7,500 well-known consumer products

Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store


2013-07-08 07:30 ET - News Release


SAN ANTONIO, TEXAS -- (Marketwired) -- 07/08/13


Bio-Solutions Corp. (OTCQB:BISU)(PINKSHEETS:BISU) (www.BioSolutionsCorp.com) has done it! In this first step to the company's expansion process across the USA and commitment to growth across America, management celebrates the national roll-out of its flagship product Type2Defense(TM) on the Healthy Provisions Amazon store via its partnership agreement with Kee Holdings Inc. The product can be purchased by following the online ordering link on the company website at: www.biosolutionscorp.com.

Kee Holdings Inc. is a leading procurer of health, nutrition and wellness products leading the way to many of the internet giants online today. Since 2006, Kee Holdings has grown to represent over 7,500 well-known consumer products and offers both wholesale and drop ship fulfillment strategies to clients such as Amazon.com and Overstock.com. Kee Holdings will be managing all product orders and shipping for Bio-Solution Corp's on-line sales.

Type2Defense(TM) is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

"We are very excited to be bringing Type2Defense(TM) to the consumer on the Healthy Provisions Amazon store and we highly appreciate the support that Amazon and its partners offer to manufacturers and suppliers. We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2Defense(TM) is aimed at filling in that gap and our company is confident that it will benefit from the $15 billion dollar U.S diabetes market," said Bill Gallagher, president and CEO at Bio-Solutions Corporation.

Consumers can find more information about the product by going to http://www.biosolutionscorp.com/products/.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.


Contacts:
Bio-Solutions Corp.
William Gallagher
Chief Executive Officer
210-373-8104
[e-mail]

Bio-Solutions Corp.
Josh Williams
Endorsement Deal Coordinator
312-636-1471
[e-mail]
www.biosolutionscorp.com

[balamidas]

good morning MOMO~

[AliAngel]

106 million float and well worth a buy here.

[Abondanceinvest]

BISU...MEDICAL MARIJUANA COULD BE THE_PATH_TO_WELLNESS_AND_PROSPERITY
http://www.biosolutionscorp.com/blog/medical-marijuana-could-be-the-path-to-wellness-and-prosperity/

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[TheFinalCD]

SREH-DSCR-MEDT 3 Bottom plays

[Abondanceinvest]

BISU-Top line revenue should explode_as_we_roll_out_professional athlete endorsements for the product by players in the NHL, NFL, NBA and MLB. )))) $$ news to follow..


BISU__mons$ter_DD_Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders
http://www.stockwatch.com/News/Item.aspx?bid=U-i885375001-U%3aBISU-20130709&symbol=BISU®ion=U


Bio-Solutions Corporation Comments on Unusual Trading Activity
http://www.stockwatch.com/News/Item.aspx?bid=U-i885374001-U%3aBISU-20130709&symbol=BISU®ion=U


Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store
http://www.stockwatch.com/News/Item.aspx?bid=U-i885104001-U%3aBISU-20130708&symbol=BISU®ion=U



http://www.biosolutionscorp.com/products/
((runner in preparation!!!!!

2013-06-27 08:45 ET - News Release
SAN ANTONIO, TEXAS -- (Marketwired) -- 06/27/13
Bio-Solutions Corporation (OTCBB:BISU)(PINKSHEETS:BISU) is pleased to announce that the company has completed its initial order of the diabetic product Type2 Defense with Nutricap Labs located in Farmingdale, New York. The successful completion of the initial production order is an important milestone for Bio-Solutions Corporation. The company is now positioned to distribute final product samples to the different groups that are presently considering endorsing the Type2 Defense product and begin set-up of proper distribution channels for the product.

Type2 Defense is a preventative supplement for people who are diabetic or who are pre-diabetic. The product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant. "The company recognizes the diabetic epidemic that is happening in this country and throughout the world. We are excited to now be able to offer such a dynamic nutritional supplement that supports healthy living in the diabetic community" says CEO Bill Gallagher.


Contacts:
William Gallagher
Chief Executive Officer
Bio-Solutions Corporation
210-218-4475
[e-mail]




BISU recent filng 10-Q ++More..DD..must>>>read May 6, 2013 Mar 31, 2013
http://www.otcmarkets.com/stock/BISU/filings


http://www.stockwatch.com/News/Item.aspx?bid=U-i875030001-U%3aBISU-20130520&symbol=BISU®ion=U


Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp-UPDATE
2013-05-20 13:02 ET - News Release


CHICAGO, ILLINOIS -- (Marketwired) -- 05/20/13


Bio-Solutions Corporation (OTCBB:BISU)(PINKSHEETS:BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal involving their diabetic product, Type-2 Defense, which is a preventative supplement for people who are diabetic or who are pre-diabetic. This product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant.

Bio-Solutions and Mark Block, who is head of the Jay Cutler Foundation, have been involved in preliminary talks concerning the endorsement deal for the past 4 weeks with outside consultants who were brought in by Bio-Solutions. They brought in outside consultants whose sole purpose was to find the best suitable athletes to endorse their Type-2 Defense product and carry their company's mission while representing their vision.

Bio-Solutions recognizes Jay Cutler as the best possible candidate because of his long-term battle with type-1 diabetes and his generosity in helping others who suffer from diabetes. Cutler, who established the Jay Cutler Foundation, raises money for diabetes research and to help children with type-1 diabetes.

Type-2 Defense samples are in the process of being shipped to Mark Block in Nashville, Tennessee where after received they will contact the National Football League to confirm that all the ingredients are compatible with the National Football Leagues' collective bargaining agreement. Bio-Solutions' Type-2 Defense samples should arrive to Block Agency in Nashville at the end of this week.

Jay Cutler will be looking over the Type-2 Defense product and the proposed endorsement deal over the next week and will make a decision on whether or not to take on this endorsement deal and team up with Bio-Solutions Corporation.


Contacts:
Josh Williams
Endorsement Deal Coordinator
Cell Phone: [phone]
[e-mail]


by : Josh Williams
NFL Analyst
Fox Sports Radio - 95.7 The Fan
[e-mail]
1-312-636-1471
http://www.stockwatch.com/News/Item.aspx?bid=U-i874782001-U%3aBISU-20130520&symbol=BISU®ion=U



Product on line soon!! For JULY!!!!!!!
Bio-Solutions Corp. has launched the new product - Type2 Defense™ - to tap into the rapidly growing demand for diabetic and functional supplementation. Type2 Defense™ will soon be sold on the company’s website www.type2defense.com (currently under development).

BISU partner
www.nutricaplabs.com/ ( fortune500 ) agreement$$


BISU_Dana Vice President of the UK’s_Naturopathic_Nutrition Association (NMA).

HIGHLY REGARDED NATUROPATH_TO JOIN BIO-SOLUTIONS

Bio-Solutions Corp is pleased to announce the addition of Ms. Dana Kraft as a team member. Ms. Kraft is a UK-trained Naturopath, specialist in Nutritional Therapy, Herbal Medicine and Flower Essence Therapy.

Upon completing her Masters dissertation in Media and Alternative Medicine at Goldsmiths College, University of London in 2005, Ms. Kraft realized that her real passion lay in natural medicine. Dana earned her diplomas at the prestigious College of Naturopathic Medicine (CNM) in London, graduating with qualifications in Nutritional Therapy, Herbal Medicine and Naturopathy. Dana also holds a BA in Communications from Tulane University and is co-founder and former Vice President of the UK’s Naturopathic Nutrition Association (NMA).

Philosophy and Approach

The European style of naturopathy is an ‘eclectic’ approach to healing. Various tools and perspectives are incorporated in order to help set each individual on the right healing path. Herbal remedies, nutrition advice, flower essences, lifestyle changes and more will be recommended to clients as deemed appropriate for the individual. Dana often uses Traditional Chinese Medicine and/or Ayurvedic theory and diagnostic techniques (tongue and pulse analysis, face reading, etc.) as well as the use of Iridology, the study of the iris of the eye, to ascertain constitutional weakness and confirm suspected areas of disease in the body.

All of Dana’s work is guided by the fundamental principles of naturopathy:

The WHOLE person is treated – physically, mentally, emotionally and spiritually.

The PERSON is treated, not the disease, and each individual is unique and responds in a different way to different remedies.

The root (underlying) cause of dysfunction is identified and treated, not the branches (symptoms).

Vis Medicatrix Naturae – The healing power of nature. There is ‘vital force’ or ‘life force’ which given the right conditions, will self-heal or self-correct.

Health is much greater than just ‘absence of infirmity’ – it should be abundant vitality.

Prevention is preferable to cure.

Bio-Solutions Corp would like to welcome Ms. Kraft to our organization and look forward to working with her in the development of future products/ brands.

Bio-Solutions Corp, Owns and Markets Type2 Defense(TM) (the “Product” or the “Supplement”) is a glucose control dietary supplement powder formulated to support healthy glucose levels in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to help support healthy glucose levels for type 2 diabetics and pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.



HOW TO JACK UP YOUR PROFITS OF MCDONALDS CORP..*BISU* doesn’t like what is going on at MCD but we plan to be there when people need us. Keep an eye on your diet and your investment portfolio.

McDonalds Corp is a staple. Everyone knows McDonalds. There are McDonalds on every street corner, or so it seems. Kids grow up loving McDonalds and the Golden Arches show up as sponsors of athletic and charitable events. Ronald McDonald is part of American culture and we as a society are paying the ultimate price. The corporation known for cheap food has suffered in the court of public opinion with the release of the Super Size Me documentary. This 2004 film by Morgan Spurlock examined the effects of eating McDonalds food for 30 straight days. The results were an eye opener for America but unfortunately the steady McDonalds diet is fact not fiction for large parts of many American ghettos. In some parts of cities like LA; you have no choice but to dine on McDonalds every night because grocery stores can’t open and expect to make a profit. Families in those areas are to broke, busy (with two jobs) or transient to shop in regular markets. In those areas, McDonalds is the fast and quick solution to everything when to comes to nutrition.
This diet disaster is helping to fuel the diabetes epidemic sweeping across the US. Investors in McDonalds are making a killing as people are getting fatter and sicker. This trend might be about to turn the corner. Jumba Juice and Chipotle Mexican Grill have recognized that consumers went healthier choices and McDonalds is trying to play catch up. There healthy options are now available but the fact remains that the cheaper traditional calories laden choices will remain favorites. It is now our place to pass judgement on McDonalds. They are free to run their company in any manner they see fit. We can however recognize the opportunity by telling investors that they could both hedge and profit from existing McDonalds (MCD) investments. The obvious way to benefit from more sales out of McDonalds is to invest in companies in the diabetes space. The bigger the pool of unhealthy people, the more profit there is to be had for companies in the diabetes space.
BISU doesn’t like what is going on at MCD but we plan to be there when people need us. Keep an eye on your diet and your investment portfolio. We want you to be wealthy but we also want you to be healthy. We welcome any question you have on our product and company. Please do not hesitate to email us on the information portion on the website.
Related articles

http://www.biosolutionscorp.com/blog/how-to-jack-up-your-profits-of-mcdonalds-corp/


http://www.biosolutionscorp.com/



Diabates Demographics - Diabetes will become a bigger and bigger isssue.

THE DEMOGRAPHICS OF DIABETES ATTRACTS INVESTORS TO THE NYSE, OTCBB, AND THE TSXV
http://www.biosolutionscorp.com/blog/the-demographics-of-diabetes-attracts-investors-to-the-nyse-otcbb-and-the-tsxv/
Total prevalence of diabetes
Total: 25.8 million children and adults in the United States—8.3% of the population—have diabetes.

Diagnosed: 18.8 million people

Undiagnosed: 7.0 million people

Prediabetes: 79 million people*

New Cases: 1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.

* In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and prediabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and prediabetes. These tests were chosen because they are most frequently used in clinical practice.


Under 20 years of age

215,000, or 0.26% of all people in this age group have diabetes
About 1 in every 400 children and adolescents has diabetes
Age 20 years or older

25.6 million, or 11.3% of all people in this age group have diabetes
Age 65 years or older

10.9 million, or 26.9% of all people in this age group have diabetes
Men

13.0 million, or 11.8% of all men aged 20 years or older have diabetes
Women

12.6 million, or 10.8% of all women aged 20 years or older have diabetes
Race and ethnic differences in prevalence of diagnosed diabetes
After adjusting for population age differences, 2007-2009 national survey data for people diagnosed with diabetes, aged 20 years or older include the following prevalence by race/ethnicity:

7.1% of non-Hispanic whites
8.4% of Asian Americans
12.6% of non-Hispanic blacks
11.8% of Hispanics
Among Hispanics rates were:

7.6% for Cubans
13.3% for Mexican Americans
13.8% for Puerto Ricans.
Morbidity and Mortality
In 2007, diabetes was listed as the underlying cause on 71,382 death certificates and was listed as a contributing factor on an additional 160,022 death certificates. This means that diabetes contributed to a total of 231,404 deaths.
Complications
Heart disease and stroke

In 2004, heart disease was noted on 68% of diabetes-related death certificates among people aged 65 years or older.
In 2004, stroke was noted on 16% of diabetes-related death certificates among people aged 65 years or older.
Adults with diabetes have heart disease death rates about 2 to 4 times higher than adults without diabetes.
The risk for stroke is 2 to 4 times higher among people with diabetes.
High blood pressure

In 2005-2008, of adults aged 20 years or older with self-reported diabetes, 67% had blood pressure greater than or equal to 140/90 mmHg or used prescription medications for hypertension.
Blindness

Diabetes is the leading cause of new cases of blindness among adults aged 20–74 years.
In 2005-2008, 4.2 million (28.5%) people with diabetes aged 40 years or older had diabetic retinopathy, and of these, almost 0.7 million (4.4% of those with diabetes) had advanced diabetic retinopathy that could lead to severe vision loss.
Kidney disease

Diabetes is the leading cause of kidney failure, accounting for 44% of new cases in 2008.
In 2008, 48,374 people with diabetes began treatment for end-stage kidney disease in the United States.
In 2008, a total of 202,290 people with end-stage kidney disease due to diabetes were living on chronic dialysis or with a kidney transplant in the United States.
Nervous system disease (Neuropathy)

About 60% to 70% of people with diabetes have mild to severe forms of nervous system damage.
Amputation

More than 60% of nontraumatic lower-limb amputations occur in people with diabetes.
In 2006, about 65,700 nontraumatic lower-limb amputations were performed in people with diabetes.
Cost of Diabetes
Updated March 6, 2013

$245 billion: Total costs of diagnosed diabetes in the United States in 2012
$176 billion for direct medical costs
$69 billion in reduced productivity
After adjusting for population age and sex differences, average medical expenditures among people with diagnosed diabetes were 2.3 times higher than what expenditures would be in the absence of diabetes.

Read more about the results of our study "Economic Costs of Diabetes in the U.S. in 2012.”

For Additional Information
These statistics and additional information can be found in the National Diabetes Fact Sheet, 2011, the most recent comprehensive assessment of the impact of diabetes in the United States, jointly produced by the CDC, NIH, ADA, and other organizations.

You can download the Association's two-page summary in PDF format from DiabetesPro.

Want to Do Something About It?
Don't like these numbers? We don't either.

Join the Millions? in the fight to Stop Diabetes®!

Make a donation to the American Diabetes Association to help fund leading-edge research that affects the health and well-being of millions of people living with diabetes. Your funds are put to work immediately to support important research efforts and help provide much needed services to people with diabetes.


@@@Diabetes cases to grow to 29 million in 2050 in the US @@@@



NATURAL REMEDIES LIKE MEDICAL MARIJUANA CAN IMPACT DIABETES
http://www.biosolutionscorp.com/blog/natural-remedies-like-medical-marijuana-can-impact-diabetes/

BISU value for 2013-2014 0.30-0.50 Under 0.10 big buyers coming


>>>>>>Type 2 Diabetes Set to Explode in the US <<<<<


BISU IN A MULTI BILLION-DOLLAR_MARKET-AND_LOOKING_AT ANOTHER
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/



BISU.MEDICAL MARIJUANA COULD BE THE_PATH_TO_WELLNESS_AND_PROSPERITY
http://www.biosolutionscorp.com/blog/medical-marijuana-could-be-the-path-to-wellness-and-prosperity/

MEDICAL MARIJUANA COULD BE THE PATH TO WELLNESS AND PROSPERITY
Our company entered the natural remedy field with our initial product offering to help diabetes patients deal with their condition. We have big plans for the roll out including endorsement deals with NFL and NHL athletes. These endorsement deals are in the advanced discussion stage and we anticipate being in a position to release news on these undertakings before month end. This product is at the core of our company’s mission to build our reputation as a Natural Remedy Company.
Searching for new opportunities is a lynchpin to our growth strategy. We have ben watching the whole medical marijuana debate with keen interest. Our group is interested in the sector because of the natural remedy component.
http://www.bottomlinepublications.com/content/article/natural-remedies/medical-marijuana
The addition of a medical marijuana project to our product portfolio could propel growth and put the company in an enviable position by being immediately accretive. A series of projects are under consideration and we will release news as soon as a final decision is made by management. This is an important decision given the potential positive impact in terms of building value for our shareholders. Companies like Medbox Inc. (http://www.thedispensingsolution.com/) and Medical Marijuana Inc. (http://www.medicalmarijuanainc.com/) have been trailblazers in the space and in the process they have created enormous wealth for investors. We think we could do the same by chosing the right project.


BISU THIS YEAR WILL BE A LANDMARK YEAR FOR_TYPE 2 DEFENSE
http://www.biosolutionscorp.com/blog/this-year-will-be-a-landmark-year-for-type-2-defense/


THIS YEAR WILL BE A LANDMARK YEAR FOR TYPE 2 DEFENSE

We are very excited to enter this new year with high hopes and expectations. The company has gone through intensive periods of startegic planning and we are confident that we are well positioned to deliver on the core product line for Bio-Solutions Corp. As shareholders know, we are preparing to market Type 2 Defense and it is our belief that the marketplace will be very receptive to the the superior formulation of this unique product in the diabetes space.
Americans are suffering from diabetes in growing numbers, The demographics point to a 100% + increase in cases to almost 30 million by 2050. This huge jump in cases bodes well for our product and the sales should reflect that this year and in years to come. Our expectation for Type 2 Defense are very high and the management team will be working hard to make sure that shareholders share in the rewards of a product has all the earmarks of a winner.
Bio-Solutions plans for Type 2 Defense include athlete endorsements, regional and countrywide distribution and media events (US and Canada). Our time is now and we are confident that we will take the opportunity to have a solid product launch and follow through. Management has established relationships with outside marketing help that has successfully marketed these type of products in the past. This will be a very interesting time to be a shareholder. We will work hard to deliver value and results and turn the share price around to more normalized levels. If you have any questions, please do not hesitate to contact us.
Related articles


BISU PROFITS AND DEALS ((NHL-NFL-MLB..endorsement..to follow..
We have been hard at work for the past four weeks and it looks like we are about ready to make our big move. Our Type 2 Defense product is in full production mode and the roll out is set to begin early next month. This diabetes product has a huge market and healthy margins. We intend to have an aggressive online marketing campaign with this product as the focal point. The sales effort will be anchored by endorsements from some of the professional athletes we are talking with at this time. Having the endorsement of MLB, NFL and NHL: players will create organic visibility for the product launch. The generous margins for Type 2 Defense will allow the company to become cash flow positive very quickly. A successful Type 2 Defense launch will be a template for other products in our pipeline.
Our shareholders can also expect to see some acquisition news, shortly. The company has been investigating many natural remedy opportunities including some in the medical marijuana space. The medical marijuana opportunities offered to the company have significant upside so makinga decision is not a simple as it would seem. The variety of these projects has led to a longer than expected due diligence period but we are winding this process down and we think we will be a in a position to make an announcement very soon. Management is focused on insuring that the new opportunities are in sync with the focus on natural remedies and have the same margin profile as our primary product.
RELATED POSTS

http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/


BISU .. NFL johnson is sensitive to the_cause_of_diabetes.read
http://bleacherreport.com/articles/1598137-nico-johnson-scouting-report-nfl-outlook-for-alabama-ilb

http://www.biosolutionscorp.com/blog/nico-johnson-scouting-report-nfl-outlook-for-alabama-ilb/



http://www.biosolutionscorp.com/blog/meet-kendall-simmons/


http://www.dlife.com/diabetes/famous_people/sports/jay-cutler-biography
Our team will be solidly implanted in that market with Type 2 Defense and the other products in development. Top line revenue should explode as we roll out professional athlete endorsements for the product by players in the NHL, NFL, NBA and MLB.


BISU invites shareholders_$HEMP_$MJNA_$MDBX_$CLNP_$SKTO_$FITX_to consider our company and visit our website



BISU Diabetes Stocks - The perfect place to make money.


HIGH MERCURY LEVELS INCREASE_DIABETES_RISK_BY_65%
Washington: Young adults who consume high levels of mercury increase their risks for type 2 diabetes later in life by 65 percent, a new study has found. The study, led by Indiana University School of Public Health-Bloomington epidemiologist Ka He …

http://zeenews.india.com/news/health/healthy-eating/high-mercury-levels-increase-diabetes-risk-by-65_21336.html

SOLUTION = BISU product http://www.biosolutionscorp.com/products/



Nutrition May Affect Quality of Life in People with Diabetes
http://www.biosolutionscorp.com/blog/nutrition-may-affect-quality-of-life-in-people-with-diabetes

[balamidas]

RDSH 0.0003x0.0004 merger 8-k out this am ~

[Drugdoctor]

Have-you-seen the-DD-on-the-new-COPI-.0294 casino business??

Corporate Profile for new Investors;

This is worth a read, really explains the business..

http://copi.mwnewsroom.com/getattachment/670391bc-6a20-43e3-a2ff-73cd2a7dccf7/SeanieMac-Corporate-Profile-Feb--2013

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[$b_rich$]

won't be on much for the next day or so, so you all make some $$$$$$$$$:)

[~ Blue ~]

SEEK huge volume yesterday

[balamidas]

good morning MOMO~

[balamidas]

STTX(0.215) big reversal pattern is taking place ..

the stock was over 1 $ mark a week ago !!!



http://stockcharts.com/h-sc/ui?s=sttx

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[balamidas]

SEEK 0.0011x0.0012 big day tomorrow ,add the dip

[balamidas]

SEEK 0.0012 one left

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[balamidas]

good morning MOMO~

[balamidas]

Sreh Nice action today

[Hedgebunny]

You still own BIHC stock MOMO?
~~~ Does BIHC stock still own a subsidiary called BARON INTERNATIONAL INC?
https://www.facebook.com/pages/BIH-Corporation/245302853672?id=245302853672&sk=info
~~~~~~~~ YOU remember PRSU.pk stock called PRIME RESTAURANT INC back in 2007? Here it is in this link being regarded, ONLY THE SUBSIDIARY IS FAIRFAX HOLDINGS!!
http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapid=12036970
~~~ Any ideas WHY MOMO??? Is it because PRSU.PK stock has the advertising logo of PRIME RESTAURANT ROYALT FUND in this 20o7 link?

[Hedgebunny]

PRSU/BIHC = FAIRFAX HOLDINGS SUBSIDIARY??
~~~~ HEY MOMO, this link is talking about PRIME RESTAURANT INC (PRSU.PK) stock back in 2007!!! PRIME RESTAURANT ROYALTY FUND hadn't changed their name to PRIME RESTAURANT INC until 2011...
http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapid=12036970
~~~ SO, is BIHC STOCK A SUBSIDIARY OF FAIRFAX FINANCIAL ???